Eight-week Sports Injury Prevention Program
ConditionHealth Adult Subjects
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18-45
SponsorPrincess Nourah Bint Abdulrahman University
About this trial
This study aims to find out whether an 8-week sports injury prevention program can improve lower-body performance-such as power, agility, and balance-among female college athletes in Saudi Arabia.
Sports participation has increased among women in Saudi Arabia, but many injury-prevention programs were originally designed for male athletes and may not meet the specific needs of females. This study will help determine whether a tailored program can reduce injury risks and improve athletic performance.
Female athletes aged 18-35 years who have been training and competing for at least one year can participate. Athletes with recent injuries, pregnancy, or chronic medical conditions that could affect performance will not be included.
Participants will complete tests before and after the program, including jumping, balance, and agility assessments. The prevention program includes warm-up exercises, stretching, strengthening, jumping drills, balance work, and agility training.
By comparing results before and after the program, the study will show whether this type of training can help female athletes stay safer and perform better.
Eligibility criteria
Qualifiers
Female athletes aged 18-35 years
Actively participating in organized sports in Saudi Arabia
Minimum of one year of continuous experience in their sport
Currently engaged in regular training and/or competition
Disqualifiers
Any recent injury within the past six months that limits performance
Pregnancy at the time of enrollment
Diagnosis of a chronic medical condition that may affect performance (e.g., uncontrolled diabetes, uncontrolled hypertension)
Any condition that could interfere with safe participation in physical testing or training
Trial design
Treatments tested in this trial
- 8-Week Sports Injury Prevention Program
Treatment groups
30 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov